COMMON STOCK PURCHASE WARRANT Hemispherx Biopharma, Inc.Common Stock Purchase Warrant • February 6th, 2019 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_____]1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Hemispherx Biopharma, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s ri
Hemispherx Biopharma, Inc. and American Stock Transfer & Trust Company, LLC, as Warrant Agent Warrant Agency Agreement Dated as of February __, 2019 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • February 6th, 2019 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • New York
WARRANT AGENCY AGREEMENT, dated as of February __, 2019 (“Agreement”), between Hemispherx Biopharma, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a [_____ company (the “Warrant Agent”).
Hemispherx Biopharma, Inc. DEALER-MANAGER AGREEMENTDealer-Manager Agreement • February 6th, 2019 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • New York
